blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3737424

EP3737424 - COMPOSITIONS AND METHODS FOR FACILITATING DELIVERY OF SYNTHETIC NUCLEIC ACIDS TO CELLS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  16.10.2020
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  19.07.2019
Most recent event   Tooltip15.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Translate Bio MA, Inc.
29 Hartwell Avenue
Lexington, MA 02421 / US
[2020/47]
Inventor(s)01 / BHAT, Balkrishen
911 Rosemary Avenue
Carlsbad, CA 92011 / US
02 / TAY, Jia
11 Marian Road
Acton, MA 01720 / US
03 / KARMAKAR, Saswata
606 South Street, Apt. 4B
Waltham, MA 02453 / US
04 / CHAU, Nelson
114 Edwardel Road
Needham, MA 02492 / US
 [2020/47]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2020/47]Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
Application number, filing date19738098.310.01.2019
[2020/47]
WO2019US13070
Priority number, dateUS201862615577P10.01.2018         Original published format: US 201862615577 P
[2020/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019140102
Date:18.07.2019
Language:EN
[2019/29]
Type: A1 Application with search report 
No.:EP3737424
Date:18.11.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 18.07.2019 takes the place of the publication of the European patent application.
[2020/47]
Search report(s)International search report - published on:KR18.07.2019
(Supplementary) European search report - dispatched on:EP23.09.2021
ClassificationIPC:A61K47/54, A61K47/61, A61K48/00, A61K38/45, A61P25/00, A61P37/00
[2021/43]
CPC:
A61K47/549 (EP,US); A61K38/45 (US); A61K31/7088 (EP);
A61K31/7105 (EP); A61K31/712 (EP); A61K31/7125 (EP);
A61P25/00 (EP); A61P37/00 (EP); C12N15/113 (EP,US);
C12N15/87 (EP); C12N9/1018 (EP); C12Y201/03003 (EP,US);
C12N2310/3231 (EP,US); C12N2310/3515 (EP); C12N2310/3519 (US) (-)
C-Set:
A61K31/7088, A61K2300/00 (EP);
A61K31/7105, A61K2300/00 (EP);
A61K31/7125, A61K2300/00 (EP);
A61K31/712, A61K2300/00 (EP)
Former IPC [2020/47]A61K48/00, A61K47/54, A61K47/61, A61K38/45, A61P25/00, A61P37/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/47]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ERLEICHTERUNG DER ABGABE VON SYNTHETISCHEN NUKLEINSÄUREN AN ZELLEN[2020/47]
English:COMPOSITIONS AND METHODS FOR FACILITATING DELIVERY OF SYNTHETIC NUCLEIC ACIDS TO CELLS[2020/47]
French:COMPOSITIONS ET MÉTHODES POUR FACILITER L'ADMINISTRATION D'ACIDES NUCLÉIQUES SYNTHÉTIQUES DANS DES CELLULES[2020/47]
Entry into regional phase20.07.2020National basic fee paid 
20.07.2020Search fee paid 
20.07.2020Designation fee(s) paid 
20.07.2020Examination fee paid 
Examination procedure20.07.2020Examination requested  [2020/47]
17.05.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
27.07.2022Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
27.07.2022Request for further processing filed
27.07.2022Full payment received (date of receipt of payment)
Request granted
05.08.2022Decision despatched
Fees paidRenewal fee
27.01.2021Renewal fee patent year 03
27.01.2022Renewal fee patent year 04
14.12.2022Renewal fee patent year 05
14.12.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2014179620  (ISIS PHARMACEUTICALS INC [US]) [Y] 1-15 * claim 1 *;
 [XYI]WO2016130943  (RANA THERAPEUTICS INC [US]) [X] 1-5,12,13 * page 47, paragraphs 1-2 * [Y] 1-15 [I] 1-15;
 [X]WO2016205410  (MPEG LA LLC [US]) [X] 1-6,12,13 * paragraph [0089] *;
 [X]WO2017075038  (RANA THERAPEUTICS INC [US]) [X] 1-6,12,13 * page 26, lines 21-27; claim 1 *;
 [Y]  - YUANYU HUANG, "Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics", MOLECULAR THERAPY-NUCLEIC ACIDS, US, (20170301), vol. 6, doi:10.1016/j.omtn.2016.12.003, ISSN 2162-2531, pages 116 - 132, XP055485332 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.omtn.2016.12.003
International search[A]US2012071540  (LU PATRICK Y [US], et al) [A] 1-10, 71-73* See the whole document. *;
 [A]US2012136042  (MANOHARAN MUTHIAH [US], et al) [A] 1-10, 71-73 * See the whole document. *;
 [A]US2015299695  (UHLMANN EUGEN [DE], et al) [A] 1-10, 71-73 * See paragraphs [0039], [0149]-0150]; claims 1, 30, 68; figures 1A-1D. *;
 [X]WO2017075038  (RANA THERAPEUTICS INC [US]) [X] 1-10, 71-73 * See page 26, lines 21-28, page 35, lines 1-11, page 59, lines 18-30; claims 1-2, 69-72. *;
 [A]  - HUANG, Y., "Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics", Molecular Therapy: Nucleic Acids, (20170300), vol. 6, doi:doi:10.1016/j.omtn.2016.12.003, pages 116 - 132, XP055485332 [A] 1-10, 71-73 * See the whole document. *

DOI:   http://dx.doi.org/10.1016/j.omtn.2016.12.003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.